Prognostic Value of the Metabolic Response on Serial 18 F-FDG PET/CT in Pancreatic Cancer
Gut and Liver · 2025
DOI: 10.5009/gnl240458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gut and Liver, 2025. Verfasst von Jinwoo Ahn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Pancreatic Neoplasms, Fluorodeoxyglucose F18, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background/Aims: The prognostic value of serial 18F-fluorodeoxyglucose positron emission tomography/ computed tomography (18F-FDG PET/CT) for patients with borderline resectable or locally advanced pancreatic cancer who undergo conversion surgery or continue chemotherapy without surgery has not been well-established.
Methods
A retrospective analysis of patients with pancreatic ductal adenocarcinoma was conducted at Seoul National University Bundang Hospital between March 2013 and February 2022. Patients underwent PET/CT at baseline and subsequent radiologic evaluations following chemotherapy. Changes in the maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), metabolic tumor volume, and total lesion glycolysis were analyzed. Based on their treatment regimens, patients were stratified into the conversion surgery group or nonconversion surgery group. Survival outcomes and various clinical factors were assessed.
Results
Among 121 patients, 52 underwent conversion surgery, and 69 continued to receive chemotherapy without surgery. A significant reduction in the SUVmax was correlated with prolonged recurrence-free survival and overall survival in the conversion surgery group. Confirmation of a pathologic response indicated a significant association between reductions in the SUVmax and positive outcomes. Reductions in the metabolic tumor volume and total lesion glycolysis were associated with improved progression-free survival and overall survival in the nonconversion surgery group.
Conclusions
Serial PET/CT scans demonstrated prognostic value in pancreatic ductal adenocarcinoma patients, revealing distinct correlations in the conversion surgery group and nonconversion surgery group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
ORCID-Profile: Jinwoo Ahn, Yoo Sung Song, Bomi Kim, Soomin Yang, Kwangrok Jung, Jong-Chan Lee, Jaihwan Kim, Jin-Hyeok Hwang
Zitieren
APA
Ahn, J., Song, Y. S., Kim, B., Yang, S., Jung, K., Lee, J. C., Kim, J., & Hwang, J. H. (2025). Prognostic Value of the Metabolic Response on Serial 18 F-FDG PET/CT in Pancreatic Cancer. Gut and Liver. https://doi.org/10.5009/gnl240458
Vancouver
Ahn J, Song YS, Kim B, Yang S, Jung K, Lee JC, et al. Prognostic Value of the Metabolic Response on Serial 18 F-FDG PET/CT in Pancreatic Cancer. Gut and Liver. 2025. doi:10.5009/gnl240458
BibTeX
@article{Ahn2025,
author = {Ahn, Jinwoo and Song, Yoo Sung and Kim, Bomi and Yang, Soomin and Jung, Kwangrok and Lee, Jong-Chan and Kim, Jaihwan and Hwang, Jin-Hyeok},
title = {Prognostic Value of the Metabolic Response on Serial 18 F-FDG PET/CT in Pancreatic Cancer},
journal = {Gut and Liver},
year = {2025},
doi = {10.5009/gnl240458}
}
EUVIMED